{"id":8307,"date":"2026-02-05T13:00:36","date_gmt":"2026-02-05T13:00:36","guid":{"rendered":"https:\/\/www.els-solutions.com\/?p=8307"},"modified":"2026-02-06T20:40:49","modified_gmt":"2026-02-06T20:40:49","slug":"new-historical-and-regulatory-milestone-in-brazil-anvisa-publishes-rdcs-on-medicinal-cannabis","status":"publish","type":"post","link":"https:\/\/www.els-solutions.com\/en\/new-historical-and-regulatory-milestone-in-brazil-anvisa-publishes-rdcs-on-medicinal-cannabis\/","title":{"rendered":"New historical and regulatory milestone for cannabis in Brazil: ANVISA publishes new RDCs (Collegiate Board Resolutions) and advances the regulation of medicinal cannabis."},"content":{"rendered":"

Cannabis in Brazil:<\/strong><\/h1>\n


The Collegiate Board Resolutions RDC No. 1,011\/2026, RDC No. 1,012\/2026, RDC No. 1,013\/2026, RDC No. 1,014\/2026, and RDC No. 1,015\/2026<\/strong> were published in the Official Gazette of the Union.<\/h2>\n


The new resolutions establish a new benchmark for the sanitary regulatory framework of Cannabis sativa<\/em> and its derivatives in the country.<\/h3>\n


These regulations represent a relevant advancement in the consolidation of the Brazilian regulatory framework applicable to medicinal cannabis.<\/p>\n

The set of these RDCs establishes clear guidelines for scientific research and technological development.<\/p>\n

It also defines parameters for the production, importation, distribution, and medicinal use of cannabis, always under rigorous sanitary surveillance.<\/p>\n

In this context, the regulatory movement remains aligned with international best practices.<\/p>\n

Thus, it seeks to balance therapeutic access, the protection of public health, and regulatory predictability for economic agents.<\/p>\n

As a result, the impacts of these resolutions are direct and relevant for companies, patient associations, and researchers.<\/p>\n

Likewise, they affect educational institutions and other organizations interested in this segment.<\/p>\n

For this reason, the correct interpretation of the provisions becomes essential.<\/p>\n

In addition, understanding the terms of validity and the interactions with other sanitary regulations reduces regulatory and operational risks.<\/p>\n

In parallel, the new regulatory scenario requires strategic planning and documentary compliance.<\/p>\n

It also demands the review of internal processes, especially for organizations seeking sanitary authorization or expansion in the Brazilian medicinal cannabis market.<\/p>\n

The ELS Group continuously monitors these regulatory updates and analyzes their practical effects. In this way, it anticipates relevant impacts for the sector.<\/p>\n

Our work prioritizes risk mitigation and regulatory security. Thus, we provide strategic technical support for decisions aligned with the current requirements.<\/p>\n

Finally, in case of questions or interest in evaluating the impacts of these RDCs on your business model or institutional project, please contact us. We are available to provide technical, safe, and strategic guidance.<\/p>\n

Related content:<\/strong><\/p>\n

Exploring the market and regulatory opportunities of medicinal cannabis in Brazil \u2013 ELS Podcast<\/a><\/p>\n

The expansion of the cannabis market in Europe \u2013 ELS Podcast<\/a><\/p>\n

The evolution of medicinal cannabis in Portugal \u2013 ELS Board Talks<\/a><\/p>\n

How can we help with Medicinal Cannabis?<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

The Collegiate Board Resolutions (RDC) No. 1,011\/2026, No. 1,012\/2026, No. 1,013\/2026, No. 1,014\/2026, and No. 1,015\/2026 were published in the Official Gazette of the Union, establishing provisions on cannabis regulation in Brazil.<\/p>\n","protected":false},"author":9,"featured_media":8473,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"class_list":["post-8307","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-anvisa-en","category-els-group-en","category-general","category-geral-en","category-noticias-en","category-rdc-en","category-rdc-1-011-en","category-rdc-1-012-en","category-rdc-1-013-en","category-rdc-1-014-en","category-rdc-1-015-en","category-regulations","tag-anvisa-en","tag-cannabis-en","tag-els-group","tag-news","tag-rdc-en","tag-rdc-1-011-en","tag-rdc-1-012-en","tag-rdc-1-013-en","tag-rdc-1-014-en","tag-rdc-1-015-en","tag-regulations"],"yoast_head":"\nBrazil: ANVISA publishes RDCs and advances cannabis regulation<\/title>\n<meta name=\"description\" content=\"New historical and regulatory milestone in Brazil: ANVISA publishes new RDCs and advances the regulation of medicinal cannabis\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.els-solutions.com\/en\/new-historical-and-regulatory-milestone-in-brazil-anvisa-publishes-rdcs-on-medicinal-cannabis\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Brazil: ANVISA publishes RDCs and advances cannabis regulation\" \/>\n<meta property=\"og:description\" content=\"New historical and regulatory milestone in Brazil: ANVISA publishes new RDCs and advances the regulation of medicinal cannabis\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.els-solutions.com\/en\/new-historical-and-regulatory-milestone-in-brazil-anvisa-publishes-rdcs-on-medicinal-cannabis\/\" \/>\n<meta property=\"og:site_name\" content=\"ELS Group - Accelerating Innovation\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/els.solutions\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-05T13:00:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-06T20:40:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.els-solutions.com\/cms\/wp-content\/uploads\/2024\/09\/ELS-Solutions-updating-medicines-supended-1-1024x512.jpg\" \/>\n<meta name=\"author\" content=\"Marketing ELS\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Marketing ELS\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.els-solutions.com\/en\/new-historical-and-regulatory-milestone-in-brazil-anvisa-publishes-rdcs-on-medicinal-cannabis\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.els-solutions.com\/en\/new-historical-and-regulatory-milestone-in-brazil-anvisa-publishes-rdcs-on-medicinal-cannabis\/\"},\"author\":{\"name\":\"Marketing ELS\",\"@id\":\"https:\/\/www.els-solutions.com\/en\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3\"},\"headline\":\"New historical and regulatory milestone for cannabis in Brazil: ANVISA publishes new RDCs (Collegiate Board Resolutions) and advances the regulation of medicinal cannabis.\",\"datePublished\":\"2026-02-05T13:00:36+00:00\",\"dateModified\":\"2026-02-06T20:40:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.els-solutions.com\/en\/new-historical-and-regulatory-milestone-in-brazil-anvisa-publishes-rdcs-on-medicinal-cannabis\/\"},\"wordCount\":366,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.els-solutions.com\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.els-solutions.com\/en\/new-historical-and-regulatory-milestone-in-brazil-anvisa-publishes-rdcs-on-medicinal-cannabis\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.els-solutions.com\/cms\/wp-content\/uploads\/2026\/02\/medical-devices-38.png\",\"keywords\":[\"ANVISA\",\"Cannabis\",\"ELS Group\",\"News\",\"RDC\",\"RDC 1.011\",\"RDC 1.012\",\"RDC 1.013\",\"RDC 1.014\",\"RDC 1.015\",\"regulations\"],\"articleSection\":[\"ANVISA`\",\"ELS Group\",\"General\",\"Geral\",\"Not\u00edcias\",\"RDC\",\"RDC 1.011\",\"RDC 1.012\",\"RDC 1.013\",\"RDC 1.014\",\"RDC 1.015\",\"regulations\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.els-solutions.com\/en\/new-historical-and-regulatory-milestone-in-brazil-anvisa-publishes-rdcs-on-medicinal-cannabis\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.els-solutions.com\/en\/new-historical-and-regulatory-milestone-in-brazil-anvisa-publishes-rdcs-on-medicinal-cannabis\/\",\"url\":\"https:\/\/www.els-solutions.com\/en\/new-historical-and-regulatory-milestone-in-brazil-anvisa-publishes-rdcs-on-medicinal-cannabis\/\",\"name\":\"Brazil: ANVISA publishes RDCs and advances cannabis regulation\",\"isPartOf\":{\"@id\":\"https:\/\/www.els-solutions.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.els-solutions.com\/en\/new-historical-and-regulatory-milestone-in-brazil-anvisa-publishes-rdcs-on-medicinal-cannabis\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.els-solutions.com\/en\/new-historical-and-regulatory-milestone-in-brazil-anvisa-publishes-rdcs-on-medicinal-cannabis\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.els-solutions.com\/cms\/wp-content\/uploads\/2026\/02\/medical-devices-38.png\",\"datePublished\":\"2026-02-05T13:00:36+00:00\",\"dateModified\":\"2026-02-06T20:40:49+00:00\",\"description\":\"New historical and regulatory milestone in Brazil: ANVISA publishes new RDCs and advances the regulation of medicinal cannabis\",\"breadcrumb\":{\"@id\":\"https:\/\/www.els-solutions.com\/en\/new-historical-and-regulatory-milestone-in-brazil-anvisa-publishes-rdcs-on-medicinal-cannabis\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.els-solutions.com\/en\/new-historical-and-regulatory-milestone-in-brazil-anvisa-publishes-rdcs-on-medicinal-cannabis\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.els-solutions.com\/en\/new-historical-and-regulatory-milestone-in-brazil-anvisa-publishes-rdcs-on-medicinal-cannabis\/#primaryimage\",\"url\":\"https:\/\/www.els-solutions.com\/cms\/wp-content\/uploads\/2026\/02\/medical-devices-38.png\",\"contentUrl\":\"https:\/\/www.els-solutions.com\/cms\/wp-content\/uploads\/2026\/02\/medical-devices-38.png\",\"width\":1200,\"height\":1200,\"caption\":\"Novo marco hist\u00f3rico e regulat\u00f3rio no Brasil: ANVISA publica novas RDCs e avan\u00e7a na regula\u00e7\u00e3o de Cannabis Medicinal\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.els-solutions.com\/en\/new-historical-and-regulatory-milestone-in-brazil-anvisa-publishes-rdcs-on-medicinal-cannabis\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\/\/www.els-solutions.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"New historical and regulatory milestone for cannabis in Brazil: ANVISA publishes new RDCs (Collegiate Board Resolutions) and advances the regulation of medicinal cannabis.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.els-solutions.com\/en\/#website\",\"url\":\"https:\/\/www.els-solutions.com\/en\/\",\"name\":\"ELS Group - Accelerating Innovation\",\"description\":\"Assessoria estrat\u00e9gia para a Ind\u00fastria Farmac\u00eautica\",\"publisher\":{\"@id\":\"https:\/\/www.els-solutions.com\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.els-solutions.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.els-solutions.com\/en\/#organization\",\"name\":\"ELS Group - Accelerating Innovation\",\"url\":\"https:\/\/www.els-solutions.com\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.els-solutions.com\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png\",\"contentUrl\":\"https:\/\/www.els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png\",\"width\":2226,\"height\":1080,\"caption\":\"ELS Group - Accelerating Innovation\"},\"image\":{\"@id\":\"https:\/\/www.els-solutions.com\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/els.solutions\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.els-solutions.com\/en\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3\",\"name\":\"Marketing ELS\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.els-solutions.com\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/c945586ccc1c6eea9e5fe73a99204736?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/c945586ccc1c6eea9e5fe73a99204736?s=96&d=mm&r=g\",\"caption\":\"Marketing ELS\"},\"sameAs\":[\"https:\/\/www.els-solutions.com\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Brazil: ANVISA publishes RDCs and advances cannabis regulation","description":"New historical and regulatory milestone in Brazil: ANVISA publishes new RDCs and advances the regulation of medicinal cannabis","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.els-solutions.com\/en\/new-historical-and-regulatory-milestone-in-brazil-anvisa-publishes-rdcs-on-medicinal-cannabis\/","og_locale":"en_US","og_type":"article","og_title":"Brazil: ANVISA publishes RDCs and advances cannabis regulation","og_description":"New historical and regulatory milestone in Brazil: ANVISA publishes new RDCs and advances the regulation of medicinal cannabis","og_url":"https:\/\/www.els-solutions.com\/en\/new-historical-and-regulatory-milestone-in-brazil-anvisa-publishes-rdcs-on-medicinal-cannabis\/","og_site_name":"ELS Group - Accelerating Innovation","article_publisher":"https:\/\/www.facebook.com\/els.solutions\/","article_published_time":"2026-02-05T13:00:36+00:00","article_modified_time":"2026-02-06T20:40:49+00:00","og_image":[{"url":"https:\/\/www.els-solutions.com\/cms\/wp-content\/uploads\/2024\/09\/ELS-Solutions-updating-medicines-supended-1-1024x512.jpg"}],"author":"Marketing ELS","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Marketing ELS","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.els-solutions.com\/en\/new-historical-and-regulatory-milestone-in-brazil-anvisa-publishes-rdcs-on-medicinal-cannabis\/#article","isPartOf":{"@id":"https:\/\/www.els-solutions.com\/en\/new-historical-and-regulatory-milestone-in-brazil-anvisa-publishes-rdcs-on-medicinal-cannabis\/"},"author":{"name":"Marketing ELS","@id":"https:\/\/www.els-solutions.com\/en\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3"},"headline":"New historical and regulatory milestone for cannabis in Brazil: ANVISA publishes new RDCs (Collegiate Board Resolutions) and advances the regulation of medicinal cannabis.","datePublished":"2026-02-05T13:00:36+00:00","dateModified":"2026-02-06T20:40:49+00:00","mainEntityOfPage":{"@id":"https:\/\/www.els-solutions.com\/en\/new-historical-and-regulatory-milestone-in-brazil-anvisa-publishes-rdcs-on-medicinal-cannabis\/"},"wordCount":366,"commentCount":0,"publisher":{"@id":"https:\/\/www.els-solutions.com\/en\/#organization"},"image":{"@id":"https:\/\/www.els-solutions.com\/en\/new-historical-and-regulatory-milestone-in-brazil-anvisa-publishes-rdcs-on-medicinal-cannabis\/#primaryimage"},"thumbnailUrl":"https:\/\/www.els-solutions.com\/cms\/wp-content\/uploads\/2026\/02\/medical-devices-38.png","keywords":["ANVISA","Cannabis","ELS Group","News","RDC","RDC 1.011","RDC 1.012","RDC 1.013","RDC 1.014","RDC 1.015","regulations"],"articleSection":["ANVISA`","ELS Group","General","Geral","Not\u00edcias","RDC","RDC 1.011","RDC 1.012","RDC 1.013","RDC 1.014","RDC 1.015","regulations"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.els-solutions.com\/en\/new-historical-and-regulatory-milestone-in-brazil-anvisa-publishes-rdcs-on-medicinal-cannabis\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.els-solutions.com\/en\/new-historical-and-regulatory-milestone-in-brazil-anvisa-publishes-rdcs-on-medicinal-cannabis\/","url":"https:\/\/www.els-solutions.com\/en\/new-historical-and-regulatory-milestone-in-brazil-anvisa-publishes-rdcs-on-medicinal-cannabis\/","name":"Brazil: ANVISA publishes RDCs and advances cannabis regulation","isPartOf":{"@id":"https:\/\/www.els-solutions.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.els-solutions.com\/en\/new-historical-and-regulatory-milestone-in-brazil-anvisa-publishes-rdcs-on-medicinal-cannabis\/#primaryimage"},"image":{"@id":"https:\/\/www.els-solutions.com\/en\/new-historical-and-regulatory-milestone-in-brazil-anvisa-publishes-rdcs-on-medicinal-cannabis\/#primaryimage"},"thumbnailUrl":"https:\/\/www.els-solutions.com\/cms\/wp-content\/uploads\/2026\/02\/medical-devices-38.png","datePublished":"2026-02-05T13:00:36+00:00","dateModified":"2026-02-06T20:40:49+00:00","description":"New historical and regulatory milestone in Brazil: ANVISA publishes new RDCs and advances the regulation of medicinal cannabis","breadcrumb":{"@id":"https:\/\/www.els-solutions.com\/en\/new-historical-and-regulatory-milestone-in-brazil-anvisa-publishes-rdcs-on-medicinal-cannabis\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.els-solutions.com\/en\/new-historical-and-regulatory-milestone-in-brazil-anvisa-publishes-rdcs-on-medicinal-cannabis\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.els-solutions.com\/en\/new-historical-and-regulatory-milestone-in-brazil-anvisa-publishes-rdcs-on-medicinal-cannabis\/#primaryimage","url":"https:\/\/www.els-solutions.com\/cms\/wp-content\/uploads\/2026\/02\/medical-devices-38.png","contentUrl":"https:\/\/www.els-solutions.com\/cms\/wp-content\/uploads\/2026\/02\/medical-devices-38.png","width":1200,"height":1200,"caption":"Novo marco hist\u00f3rico e regulat\u00f3rio no Brasil: ANVISA publica novas RDCs e avan\u00e7a na regula\u00e7\u00e3o de Cannabis Medicinal"},{"@type":"BreadcrumbList","@id":"https:\/\/www.els-solutions.com\/en\/new-historical-and-regulatory-milestone-in-brazil-anvisa-publishes-rdcs-on-medicinal-cannabis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/www.els-solutions.com\/en\/"},{"@type":"ListItem","position":2,"name":"New historical and regulatory milestone for cannabis in Brazil: ANVISA publishes new RDCs (Collegiate Board Resolutions) and advances the regulation of medicinal cannabis."}]},{"@type":"WebSite","@id":"https:\/\/www.els-solutions.com\/en\/#website","url":"https:\/\/www.els-solutions.com\/en\/","name":"ELS Group - Accelerating Innovation","description":"Assessoria estrat\u00e9gia para a Ind\u00fastria Farmac\u00eautica","publisher":{"@id":"https:\/\/www.els-solutions.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.els-solutions.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.els-solutions.com\/en\/#organization","name":"ELS Group - Accelerating Innovation","url":"https:\/\/www.els-solutions.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.els-solutions.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png","contentUrl":"https:\/\/www.els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png","width":2226,"height":1080,"caption":"ELS Group - Accelerating Innovation"},"image":{"@id":"https:\/\/www.els-solutions.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/els.solutions\/"]},{"@type":"Person","@id":"https:\/\/www.els-solutions.com\/en\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3","name":"Marketing ELS","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.els-solutions.com\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/c945586ccc1c6eea9e5fe73a99204736?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c945586ccc1c6eea9e5fe73a99204736?s=96&d=mm&r=g","caption":"Marketing ELS"},"sameAs":["https:\/\/www.els-solutions.com\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.els-solutions.com\/en\/wp-json\/wp\/v2\/posts\/8307"}],"collection":[{"href":"https:\/\/www.els-solutions.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.els-solutions.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.els-solutions.com\/en\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/www.els-solutions.com\/en\/wp-json\/wp\/v2\/comments?post=8307"}],"version-history":[{"count":3,"href":"https:\/\/www.els-solutions.com\/en\/wp-json\/wp\/v2\/posts\/8307\/revisions"}],"predecessor-version":[{"id":8498,"href":"https:\/\/www.els-solutions.com\/en\/wp-json\/wp\/v2\/posts\/8307\/revisions\/8498"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.els-solutions.com\/en\/wp-json\/wp\/v2\/media\/8473"}],"wp:attachment":[{"href":"https:\/\/www.els-solutions.com\/en\/wp-json\/wp\/v2\/media?parent=8307"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}